TRIB · NASDAQ · Medical - Specialties

Trinity Biotech (ADR) (TRIB)

Makes rapid HIV tests, haemoglobin systems and specialty clinical diagnostics.

$7.32
vs last close−0.03 (−0.41%)

In millions of USD, except per-share figures

In millionsQ1 FY23Mar 2023Q2 FY23Jun 2023Q3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025
Revenue15141513151615168111411
Cost of revenue99109101010116788
Gross profit654456552464
99988108166776
Research & development111111111111
Selling, general & administrative988676785765
Other expenses000002070000
Operating income−4−15−5−3−3−4−3−12−5−3−1−3
−2−4−2−20−3−2−4−4−3−5−15
Interest income0000001000
Interest expense3422033422413
Other non-operating income000002−1−10000
Income before tax−6−19−6−6−3−7−5−16−9−6−5−18
Income tax expense00000001000
Net income from continuing operations−6−18−7−6−3−7−5−16−6−5−17
Discontinued operations01200000−10000
Other adjustments00000000000
Net income−6−6−7−6−3−7−5−17−9−6−5−17
EPS, basic−$0.83−$0.78−$0.88−$21.60−$11.16−$21.30−$13.80−$35.88−$14.46−$9.72−$8.22−$28.20
EPS, diluted−$0.83−$0.78−$0.88−$21.60−$11.16−$21.30−$13.80−$35.88−$14.46−$9.72−$8.22−$28.20
Weighted average shares, basic888000001111
Weighted average shares, diluted888000001111
EBITDA−3−14−4−3−2−4−1−10−4−20−2
Depreciation & amortization100010101111
EBIT−4−15−4−3−3−4−2−10−5−3−1−3